InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Lippis Daniel J., CVP, JAPAC. Insider active across 1 companies, notably Edwards Lifesciences Corp. Cumulatively, 6 reports have been recorded. The latest transaction was disclosed on 6 April 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
US$52,3191,019 shares@ US$51.34360.0001% mcap33.6% of flow
Common Stock
SEC:0001225208-26-004422·
€52,3191,019 shares@ €51.34360.0001% mcap16.8% of flow
Common Stock
SEC:0001225208-26-004422:0·
US$51,7961,019 shares@ US$50.82980.0001% mcap33.3% of flow
Common Stock
SEC:0001225208-26-000558·
€51,7961,019 shares@ €50.82980.0001% mcap16.6% of flow
Common Stock
SEC:0001225208-26-000558:0·
US$51,4361,019 shares@ US$50.47660.0001% mcap33.1% of flow
Common Stock
SEC:0001225208-25-009934·
€51,4361,019 shares@ €50.47660.0001% mcap16.5% of flow
Common Stock
SEC:0001225208-25-009934:0·
6 of 6 declarations
About Lippis Daniel J.
Daniel J. Lippis is associated with Edwards Lifesciences Corp as CVP, JAPAC, and CVP, TAVR. Although his functions are not specified, he plays an important role in the company's operations in these regions.
